SOLVAC S.A.

SOLVAC S.A.

EEURONEXT:SOLV
86.50
EUR
-0.50
(-0.57%)
2.67BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
4.72
1.15
5.66
8.89
15.35
12.68
1.5
-14.6
13.71
5.71
5.96
4.9
5.86
- -
Free Cash Flow per Basic Share
4.96
4.84
4.07
5.01
5.19
5.43
5.66
5.47
5.61
5.85
-0.22
-0.14
-0.18
- -
Dividend per Share
4.35
4.35
3.6
4.82
5.01
5.24
5.43
5.43
5.43
5.57
5.81
5.81
5.81
- -
Book Value per Share
144.45
135.5
146.48
151.34
150.32
163.41
148.54
114.62
136.89
118.49
118.64
117.73
117.78
118.64
Tangible Book Value per Share
123.77
114.82
130.48
135.3
134.27
147.37
132.49
98.57
120.84
118.49
118.64
117.73
117.78
118.64
Basic Weighted Avg Shares
17
17
21
21
21
21
21
21
21
21
21
21
21
21
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
78
19
121
190
328
271
32
-312
293
122
127
105
125
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
-17
-14
-17
-5
-3
-12
-9
-19
-18
-15
-12
-81
-30
-12
LT Debt
110
110
110
160
160
150
150
150
150
150
150
100
150
150
Total Equity
2,389
2,241
3,131
3,235
3,213
3,493
3,175
2,450
2,926
2,533
2,536
2,516
2,518
2,536
Return on Invested Capital (%)
3.2
0.81
4.25
5.64
-0.03
-0.03
-0.03
- -
-0.07
-0.07
- -
-0.11
-0.15
- -
Return on Capital (%)
3.46
0.93
4.39
5.77
9.72
7.76
1.02
- -
10.25
4.27
- -
3.99
4.81
- -
Return on Common Equity (%)
3.48
0.82
4.5
5.97
10.17
8.08
0.96
-11.09
10.9
4.47
5.02
4.14
4.98
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'18
Jun'23
Dec'23
ST Debt
42
- -
49
LT Borrowings
150
- -
150
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
2,362
2,437
2,672

Working Capital

EUR

•

in mil. unless spec.
Dec'18
Jun'23
Dec'23
Total Current Assets
48
69
57
Cash, Cash Equivalents & STI
1
68
4
Accounts Receivable, Net
47
1
- -
Inventories
- -
- -
- -
Total Current Liabilities
60
5
69
Payables & Accruals
- -
- -
- -
ST Debt
42
- -
49
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.52%
1.08%
0.04%
Free Cash Flow
-7.19%
-20.83%
28.48%
Net Income, GAAP
-129.69%
-49.2%
19.69%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5.96
2024
- -
- -
4.9
2025
- -
- -
5.86

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5.81
2024
- -
- -
5.81
2025
- -
- -
5.81

Company Description

CEO
Melchior de Vogue
Full Time Employees
5
Sector
Process industries
Industry
Chemicals: specialty
Address
Rue des Champs ElysEes 43 Brussels BU Belgium 1050
IPO Date
Jan 2, 1987
Website
solvac.be
Business
Solvac S.A. is a Belgian holding company primarily engaged in managing significant long-term strategic equity investments, notably a majority stake of approximately 30.8% in Solvay S.A., a global leader in advanced materials and specialty chemicals, and a substantial stake in Syensqo S.A., which also operates in specialty chemicals. Founded in 1983 and headquartered in Brussels, Solvac does not directly manufacture products but derives its core business from its portfolio holdings in manufacturing and marketing of specialty polymers, composite materials, soda ash, peroxides, silica, coatings, plastics, chemicals, and pharmaceutical products through these subsidiaries. The company's mission centers on supporting the sustainable growth and value creation of these invested entities, which serve end markets including automotive, aerospace, electronics, medical devices, and energy sectors worldwide. Recent developments include Solvac's ongoing role as a stable reference shareholder, facilitating strategic initiatives and growth in its portfolio companies, with no recent reports of new product launches directly by Solvac but significant shareholder activity and dividend announcements reflecting its financial health and strategic positioning as an investment vehicle in advanced materials and chemical industries. Solvac operates mainly in Belgium but its investment reach and market influence are global through its holdings. The company employs a minimal direct workforce, acting as a financial and strategic holding entity rather than an operational manufacturer. This structure positions Solvac as a key investor and stabilizing force within the specialty chemicals and advanced materials sectors, focusing on shareholder returns through its controlling interests and strategic oversight of its portfolio companies' innovation and expansion efforts.